This range of KRAS mutation detection is mainly due to the following factors: different stages of pancreatic cancer examined (i.e. late stage unresectable 81% [24] vs earlier stage primary operable 27% [17]) and differences in methods and sensitivity of these methods. Here, KRAS is linked to familial pancreatic carcinoma.